I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The safety of canakinumab in systemic juvenile idiopathic a..:
Sözeri, Betül
;
Coşkuner, Taner
;
Çaglayan, Şengül
...
Expert Opinion on Biological Therapy. , 2023
Link:
https://hdl.handle.net/11499/56043
RT Journal T1
The safety of canakinumab in systemic juvenile idiopathic arthritis and autoinflammatory diseases in pediatric patients: a multicenter study
UL https://suche.suub.uni-bremen.de/peid=base-ftpamukkaleuniv:oai:gcris.pau.edu.tr:11499_56043&Exemplar=1&LAN=DE A1 Sözeri, Betül A1 Coşkuner, Taner A1 Çaglayan, Şengül A1 Akgün, Özlem A1 Torun, Ruya A1 Sunar Yayla, Emine Nur A1 Bagrul, Ä°lknur A1 Kılbaş, Gülsah A1 Yener, Gülçin Otar A1 Köse, Hülya A1 Öztürk, Kübra A1 Baba, Özge A1 Çakan, Mustafa A1 Demir, Ferhat A1 Sönmez, Hafize Emine A1 Kalyoncu, Mukaddes A1 Kılıç, Sara Sebnem A1 Bağlan, Esra A1 Bakkaloğlu, Sevcan A A1 Ünsal, Erbil A1 Aktay Ayaz, Nuray A1 Yüksel, Selçuk PB Taylor & Francis Ltd YR 2023 K1 Canakinumab K1 safety K1 autoinflammatory diseases K1 systemic juvenile idiopathic arthritis K1 Familial Mediterranean Fever K1 Macrophage Activation Syndrome K1 Double-Blind K1 Open-Label K1 Interleukin-1 K1 Efficacy K1 Pathogenesis K1 Inflammation K1 Tocilizumab K1 Children JF Expert Opinion on Biological Therapy LK http://dx.doi.org/https://hdl.handle.net/11499/56043 DO https://hdl.handle.net/11499/56043 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)